Never miss an update from Javier Montiel Bonmatí
Create your free account to connect with Javier Montiel Bonmatí and thousands of other innovative organizations and professionals worldwide
The research group of Optics and Visual Perception of the UNIVERSITY OF ALICANTE, with the collaboration of the company LABORATORIOS LENTICON SA, has developed a new multifocal scleral contact lens to compensate presbyopia (age-related near vision deterioration) which has the peculiarity of being optically customizable according to the specific needs of each patient. The new contact lens has been developed combining different types of stable optical aberrations that have allowed us to optimize the depth of focus, providing excellent levels of visual quality as well as very comfort wear, easy fitting process and greater stability than current multifocal contact lenses. Some prototypes have been manufactured at laboratory level and they have been validated successfully in patients. Currently, CE marking is being processed which will allow its international commercialization. We are looking for companies interested in acquiring this technology for commercial exploitation.
TECHNICAL DESCRIPTION
Presbyopia is a widespread problem in the population over 45 years, so it is especially relevant to develop a new multifocal contact lenses based on the optimization of depth of focus through combining different types of optical aberrations, with an easy fitting, with significant positional stability, and customizable according to the specific needs of each patient.
The present invention solves technical problems described above.
In this case, a new multifocal contact lenses has been developed to compensate presbyopia. It is made of oxygen permeable rigid material, with scleral bearing (that is, the outermost and white layer of the eyeball), which is fully customizable according to the specific anatomical properties of the eye of each patient, such as:
This novel contact lens, which allows an aligned and adequate fitting to the corneal-conjunctival profile of the patient, comprise three different areas: corneal, limbar and scleral. In turn, each of these areas has two surfaces: anterior (which is in contact with the environment), and posterior (which is the one that configures the tear meniscus retained between the cornea and the contact lens). See Figures 1 and 2.
The contact lenses are made of a gas permeable material (with high oxygen transmissibility) and with a variable overall diameter depending on the iris of the patient.
For the fitting of the contact lens, the following variables (calculated according to the post-lens tear meniscus) should be considered:
Different simulations were carried out using the standard ray tracing procedure and assuming different model eyes with different magnitudes of primary spherical aberration, which allowed us to define the most suitable aberrometric profile for the contact lens, providing optimized visual quality and depth of the desired focus, for different eye optical combinations.
A classification has also been made with different levels of decentration of the optical center at the nasal level, depending on the magnitude of the patient's kappa angle.
ADVANTAGES OF THE TECHNOLOGY
The new multifocal scleral contact lens made of oxygen permeable rigid material and with optical personalization for each patient, offers the following advantages over the designs currently on the market:
INNOVATIVE ASPECTS OF THE TECHNOLOGY
A multifocal scleral contact lens has been developed to compensate presbyopia, which is optically customizable according to the specific needs of each patient's eye.
Its development has been based on the optimization of depth of focus by combining different types of optical aberrations that are stable as no decentrations of the lens are expected due to the high stability of the bearing of the lens.
For such purpose, a wide variety of Zernike third to sixth order optical aberration induction options has been used not only according to the patient's near addition, but also according to the patient's kappa angle as well as the pupil size under different lighting conditions.
Therefore, the design has been managed to optimize the depth of focus while maintaining excellent levels of visual quality.
This novel contact lens is easily fitted, even in those patients who have a peculiar pupil dynamics or a marked kappa angle.
In addition, the optical center of this lens can be decentrated as a function of the kappa angle of the patient, thereby preventing high levels of comatic aberration in patients with a large kappa angle (for instance, in nearsighted patients).
Unlike virtually all current multifocal contact lenses, which work with induction of primary spherical aberration, it has been shown that the combination of other types of optical aberrations may induce significant increases in depth of focus without significant deterioration of the visual quality.
CURRENT STATE OF THE TECHNOLOGY
This novel multifocal scleral contact lens to compensate presbyopia (eyestrain) has been developed on a laboratory scale.
A batch of prototypes has been manufactured and successfully validatedin different patients. The manufacturing process is reliable and reproducible.
Currently, the CE marking is being processed, which will allow its commercialization at international level.
MARKET APPLICATIONS
The present invention is framed in the field of Optics. In particular, it relates to a multifocal scleral contact lens to compensate presbyopia. It is optically customizable according to the specific needs of each patient.
COLLABORATION SOUGHT
It is looking for companies interested in acquiring this invention for commercial exploitation through:
Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.
Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.
Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.
Create your free account to connect with Javier Montiel Bonmatí and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Javier
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support